Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis
Clinical trial NCT06391645 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06391645
- Sponsor
- Beijing Tiantan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2025-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.